For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Transcatheter aortic valve implantation (TAVI) is the primary therapeutic option for severe aortic stenosis that are inoperable or have high surgical risk.
Scope of the Report:
This report focuses on the Cerebral Embolic Protection Devices for TAVI in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Diffusion-weighted MRI studies demonstrates that after TAVI some silent embolic cerebral infarcts are present that lead to consecutive mental deterioration. Embolic protection devices are used to provide a mechanical barrier against the debris that cause embolization in the brain during TAVI. These devices have reduced the risk of cerebrovascular incidences related to TAVI.
The worldwide market for Cerebral Embolic Protection Devices for TAVI is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Keystone Heart
- Claret Medical
- Edwards Lifesciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Clarets Sentinel System
- Keystone Hearts Triguard Device
- Embrella Embolic Deflector
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Cerebral Embolic Protection Devices for TAVI market.
Chapter 1, to describe Cerebral Embolic Protection Devices for TAVI Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cerebral Embolic Protection Devices for TAVI, with sales, revenue, and price of Cerebral Embolic Protection Devices for TAVI, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cerebral Embolic Protection Devices for TAVI, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cerebral Embolic Protection Devices for TAVI market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cerebral Embolic Protection Devices for TAVI sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source